0001347178 2026-02-12 2026-02-12 0001347178 1 2026-02-12 2026-02-12 0001347178 2 2026-02-12 2026-02-12 0001347178 3 2026-02-12 2026-02-12 0001347178 4 2026-02-12 2026-02-12 0001347178 5 2026-02-12 2026-02-12 0001347178 6 2026-02-12 2026-02-12 iso4217:USD pure 0001347178 EX-FILING FEES S-3 S-3 Vanda Pharmaceuticals Inc. false Equity Common Stock, $0.001 par value per share true false Equity Preferred Stock, $0.001 par value per share true false Debt Debt Securities true false Other Warrants true false Other Units true false Unallocated (Universal) Shelf true 200000000 0.0001381 27620 200000000 27620 0.00 0.00 27620 <div style="padding-right:-1.88pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(1a) An indeterminate number or aggregate principal amount, as applicable, of securities of each identified class is being registered as may from time to time be offered on a primary basis at indeterminate prices, including an indeterminate number or amount of securities that may be issued upon the exercise, settlement, exchange or conversion of securities offered hereunder. Separate consideration may or may not be received for securities that are issuable upon conversion of, or in exchange for, or upon exercise of, convertible or exchangeable securities. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), this registration statement shall also cover any additional securities of the registrant that become issuable by reason of any splits, dividends or similar transactions or anti-dilution adjustments.</span></div><div style="padding-right:-1.88pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(1b) The proposed maximum offering price per class of security will be determined from time to time by the Registrant in connection with the issuance by the Registrant of the securities registered hereunder and is not specified as to each class of security pursuant to Instruction 2.A.iii.b of the Instructions to the Calculation of Filing Fee Tables and related disclosure on Form S-3.</span></div><div style="padding-right:-1.88pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(1c) Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(o) under the Securities Act.</span></div> N/A N/A